{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T22:38:39Z","timestamp":1777070319200,"version":"3.51.4"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T00:00:00Z","timestamp":1765324800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T00:00:00Z","timestamp":1765324800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Hum Genet"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1038\/s10038-025-01433-y","type":"journal-article","created":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T10:54:05Z","timestamp":1765364045000},"page":"283-291","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Genetic characterization of a Chinese cohort of suspected pediatric NF1 patients: a large-scale study using optimized whole-exome sequencing"],"prefix":"10.1038","volume":"71","author":[{"given":"Kaiyu","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miao","family":"Jing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Mao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manli","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuxiang","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mei","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fang","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Quanze","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,10]]},"reference":[{"key":"1433_CR1","doi-asserted-by":"publisher","first-page":"A:327","DOI":"10.1002\/ajmg.a.33139","volume":"152","author":"DG Evans","year":"2010","unstructured":"Evans DG, Howard E, Giblin C, Clancy T, Spencer H, Huson SM, et al. Birth incidence and prevalence of tumor-prone syndromes: estimates from a UK family genetic register service. Am J Med Genet A. 2010;152:A:327\u201332.","journal-title":"Am J Med Genet A"},{"key":"1433_CR2","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1038\/gim.2017.215","volume":"20","author":"RA Kallionpaa","year":"2018","unstructured":"Kallionpaa RA, Uusitalo E, Leppavirta J, Poyhonen M, Peltonen S, Peltonen J. Prevalence of neurofibromatosis type 1 in the Finnish population. Genet Med. 2018;20:1082\u20136.","journal-title":"Genet Med"},{"key":"1433_CR3","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1038\/jid.2014.465","volume":"135","author":"E Uusitalo","year":"2015","unstructured":"Uusitalo E, Leppavirta J, Koffert A, Suominen S, Vahtera J, Vahlberg T, et al. Incidence and mortality of neurofibromatosis: a total population study in Finland. J Investig Dermatol. 2015;135:904\u201306.","journal-title":"J Investig Dermatol"},{"key":"1433_CR4","doi-asserted-by":"crossref","unstructured":"Miller DT, Freedenberg D, Schorry E, Ullrich NJ, Viskochil D, Korf BR, et al. Health supervision for children with neurofibromatosis type 1. Pediatrics. 2019;143:e20190660.","DOI":"10.1542\/peds.2019-0660"},{"key":"1433_CR5","unstructured":"National Institutes of Health Consensus Development Conference Statement: neurofibromatosis. Bethesda, Md., USA, July 13\u201315, 1987. Neurofibromatosis. 1988;1:172\u20138."},{"key":"1433_CR6","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1212\/WNL.54.8.1646","volume":"54","author":"K DeBella","year":"2000","unstructured":"DeBella K, Poskitt K, Szudek J, Friedman JM. Use of \u201cunidentified bright objects\u201d on MRI for diagnosis of neurofibromatosis 1 in children. Neurology. 2000;54:1646\u201351.","journal-title":"Neurology"},{"key":"1433_CR7","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/B978-0-444-52902-2.00053-9","volume":"115","author":"RE Ferner","year":"2013","unstructured":"Ferner RE, Gutmann DH. Neurofibromatosis type 1 (NF1): diagnosis and management. Handb Clin Neurol. 2013;115:939\u201355.","journal-title":"Handb Clin Neurol"},{"key":"1433_CR8","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.gde.2009.04.001","volume":"19","author":"WE Tidyman","year":"2009","unstructured":"Tidyman WE, Rauen KA. The RASopathies: developmental syndromes of Ras\/MAPK pathway dysregulation. Curr Opin Genet Dev. 2009;19:230\u20136.","journal-title":"Curr Opin Genet Dev"},{"key":"1433_CR9","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1007\/s00439-020-02199-3","volume":"139","author":"PD Stenson","year":"2020","unstructured":"Stenson PD, Mort M, Ball EV, Chapman M, Evans K, Azevedo L, et al. The human gene mutation database (HGMD(R)): optimizing its use in a clinical diagnostic or research setting. Hum Genet. 2020;139:1197\u2013207.","journal-title":"Hum Genet"},{"key":"1433_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/srep11291","volume":"5","author":"J Zhang","year":"2015","unstructured":"Zhang J, Tong H, Fu X, Zhang Y, Liu J, Cheng R, et al. Molecular characterization of NF1 and neurofibromatosis Type 1 genotype-phenotype correlations in a Chinese population. Sci Rep. 2015;5:11291.","journal-title":"Sci Rep"},{"key":"1433_CR11","doi-asserted-by":"publisher","first-page":"2297","DOI":"10.1007\/s00381-020-04717-0","volume":"36","author":"H Kehrer-Sawatzki","year":"2020","unstructured":"Kehrer-Sawatzki H, Kluwe L, Salamon J, Well L, Farschtschi S, Rosenbaum T, et al. Clinical characterization of children and adolescents with NF1 microdeletions. Childs Nerv Syst. 2020;36:2297\u2013310.","journal-title":"Childs Nerv Syst"},{"key":"1433_CR12","doi-asserted-by":"crossref","unstructured":"Bianchessi D, Ibba MC, Saletti V, Blasa S, Langella T, Paterra R, et al. Simultaneous detection of NF1, SPRED1, LZTR1, and NF2 gene mutations by targeted NGS in an Italian cohort of suspected NF1 patients. Genes. 2020;11:671.","DOI":"10.3390\/genes11060671"},{"key":"1433_CR13","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1089\/gtmb.2014.0109","volume":"18","author":"R Maruoka","year":"2014","unstructured":"Maruoka R, Takenouchi T, Torii C, Shimizu A, Misu K, Higasa K, et al. The use of next-generation sequencing in molecular diagnosis of neurofibromatosis type 1: a validation study. Genet Test Mol Biomarkers. 2014;18:722\u201335.","journal-title":"Genet Test Mol Biomarkers"},{"key":"1433_CR14","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1186\/s12887-021-02791-0","volume":"21","author":"E Pinti","year":"2021","unstructured":"Pinti E, Nemeth K, Staub K, Lengyel A, Fekete G, Haltrich I. Diagnostic difficulties and possibilities of NF1-like syndromes in childhood. BMC Pediatr. 2021;21:331.","journal-title":"BMC Pediatr"},{"key":"1433_CR15","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1002\/humu.24261","volume":"42","author":"C Perez-Becerril","year":"2021","unstructured":"Perez-Becerril C, Evans DG, Smith MJ. Pathogenic noncoding variants in the neurofibromatosis and schwannomatosis predisposition genes. Hum Mutat. 2021;42:1187\u2013207.","journal-title":"Hum Mutat"},{"key":"1433_CR16","doi-asserted-by":"crossref","unstructured":"Yao R, Yu T, Xu Y, Yu L, Wang J, Wang X, et al. Clinical presentation and novel pathogenic variants among 68 Chinese neurofibromatosis 1 children. Genes. 2019;10:847.","DOI":"10.3390\/genes10110847"},{"key":"1433_CR17","doi-asserted-by":"publisher","first-page":"1978","DOI":"10.1093\/bioinformatics\/bty897","volume":"35","author":"C Kopanos","year":"2019","unstructured":"Kopanos C, Tsiolkas V, Kouris A, Chapple CE, Albarca Aguilera M, Meyer R, et al. VarSome: the human genomic variant search engine. Bioinformatics. 2019;35:1978\u201380.","journal-title":"Bioinformatics"},{"key":"1433_CR18","doi-asserted-by":"publisher","first-page":"608889","DOI":"10.3389\/fgene.2021.608889","volume":"12","author":"SP Strom","year":"2021","unstructured":"Strom SP, Hossain WA, Grigorian M, Li M, Fierro J, Scaringe W, et al. A streamlined approach to Prader-Willi and Angelman syndrome molecular diagnostics. Front Genet. 2021;12:608889.","journal-title":"Front Genet"},{"key":"1433_CR19","doi-asserted-by":"publisher","first-page":"D1333","DOI":"10.1093\/nar\/gkad1005","volume":"52","author":"MA Gargano","year":"2024","unstructured":"Gargano MA, Matentzoglu N, Coleman B, Addo-Lartey EB, Anagnostopoulos AV, Anderton J, et al. The human phenotype ontology in 2024: phenotypes around the world. Nucleic Acids Res. 2024;52:D1333\u201346.","journal-title":"Nucleic Acids Res"},{"key":"1433_CR20","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17:405\u201324.","journal-title":"Genet Med"},{"key":"1433_CR21","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/s41436-019-0686-8","volume":"22","author":"ER Riggs","year":"2020","unstructured":"Riggs ER, Andersen EF, Cherry AM, Kantarci S, Kearney H, Patel A, et al. Technical standards for the interpretation and reporting of constitutional copy-number variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics (ACMG) and the Clinical Genome Resource (ClinGen). Genet Med. 2020;22:245\u201357.","journal-title":"Genet Med."},{"key":"1433_CR22","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1016\/j.ajhg.2023.06.002","volume":"110","author":"LC Walker","year":"2023","unstructured":"Walker LC, Hoya M, Wiggins GAR, Lindy A, Vincent LM, Parsons MT, et al. Using the ACMG\/AMP framework to capture evidence related to predicted and observed impact on splicing: recommendations from the ClinGen SVI Splicing Subgroup. Am J Hum Genet. 2023;110:1046\u201367.","journal-title":"Am J Hum Genet"},{"key":"1433_CR23","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1002\/humu.23626","volume":"39","author":"AN Abou Tayoun","year":"2018","unstructured":"Abou Tayoun AN, Pesaran T, DiStefano MT, Oza A, Rehm HL, Biesecker LG, et al. Recommendations for interpreting the loss-of-function PVS1 ACMG\/AMP variant criterion. Hum Mutat. 2018;39:1517\u201324.","journal-title":"Hum Mutat"},{"key":"1433_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-022-01073-3","volume":"14","author":"JM Ellingford","year":"2022","unstructured":"Ellingford JM, Ahn JW, Bagnall RD, Baralle D, Barton S, Campbell C, et al. Recommendations for clinical interpretation of variants found in non-coding regions of the genome. Genome Med. 2022;14:73.","journal-title":"Genome Med"},{"key":"1433_CR25","doi-asserted-by":"publisher","first-page":"E173","DOI":"10.1002\/humu.20826","volume":"29","author":"E Pros","year":"2008","unstructured":"Pros E, G\u00f3mez C, Mart\u00edn T, F\u00e1bregas P, Serra E, L\u00e1zaro C. Nature and mRNA effect of 282 different NF1 point mutations: focus on splicing alterations. Hum Mutat. 2008;29:E173\u201393.","journal-title":"Hum Mutat"},{"key":"1433_CR26","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.jmoldx.2010.09.002","volume":"13","author":"MC Valero","year":"2011","unstructured":"Valero MC, Mart\u00edn Y, Hern\u00e1ndez-Imaz E, Marina Hern\u00e1ndez A, Mele\u00e1n G, Valero AM, et al. A highly sensitive genetic protocol to detect NF1 mutations. J Mol Diagn. 2011;13:113\u201322.","journal-title":"J Mol Diagn"},{"key":"1433_CR27","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1002\/humu.22392","volume":"34","author":"A Sabbagh","year":"2013","unstructured":"Sabbagh A, Pasmant E, Imbard A, Luscan A, Soares M, Blanch\u00e9 H, et al. NF1 molecular characterization and neurofibromatosis type I genotype-phenotype correlation: the French experience. Hum Mutat. 2013;34:1510\u20138.","journal-title":"Hum Mutat"},{"key":"1433_CR28","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.anpedi.2014.10.010","volume":"83","author":"A Duat Rodr\u00edguez","year":"2015","unstructured":"Duat Rodr\u00edguez A, Martos Moreno G, Mart\u00edn Santo-Domingo Y, Hern\u00e1ndez Mart\u00edn A, Espejo-Saavedra Roca JM, Ruiz-Falc\u00f3 Rojas ML, et al. [Phenotypic and genetic features in neurofibromatosis type 1 in children]. An Pediatr. 2015;83:173\u201382.","journal-title":"An Pediatr"},{"key":"1433_CR29","doi-asserted-by":"crossref","unstructured":"Bergoug M, Doudeau M, Godin F, Mosrin C, Vall\u00e9e B, B\u00e9n\u00e9detti H. Neurofibromin structure, functions and regulation. Cells. 2020;9:2365.","DOI":"10.3390\/cells9112365"},{"key":"1433_CR30","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1002\/humu.24005","volume":"41","author":"K Wimmer","year":"2020","unstructured":"Wimmer K, Schamschula E, Wernstedt A, Traunfellner P, Amberger A, Zschocke J, et al. AG-exclusion zone revisited: Lessons to learn from 91 intronic NF1 3\u2019 splice site mutations outside the canonical AG-dinucleotides. Hum Mutat. 2020;41:1145\u201356.","journal-title":"Hum Mutat"},{"key":"1433_CR31","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1086\/302809","volume":"66","author":"R Fahsold","year":"2000","unstructured":"Fahsold R, Hoffmeyer S, Mischung C, Gille C, Ehlers C, K\u00fcc\u00fckceylan N, et al. Minor lesion mutational spectrum of the entire NF1 gene does not explain its high mutability but points to a functional domain upstream of the GAP-related domain. Am J Hum Genet. 2000;66:790\u2013818.","journal-title":"Am J Hum Genet"},{"key":"1433_CR32","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1016\/j.gim.2022.02.019","volume":"24","author":"JE Hunter","year":"2022","unstructured":"Hunter JE, Jenkins CL, Bulkley JE, Gilmore MJ, Lee K, Pak CM, et al. ClinGen\u2019s Pediatric Actionability Working Group: clinical actionability of secondary findings from genome-scale sequencing in children and adolescents. Genet Med. 2022;24:1328\u201335.","journal-title":"Genet Med"},{"key":"1433_CR33","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1002\/ajmg.a.62575","volume":"188","author":"K Muthusamy","year":"2022","unstructured":"Muthusamy K, El-Jabali A, Ongie LJ, Dhamija R, Babovic-Vuksanovic D. Neurofibromatosis 1 in the setting of dual diagnosis: diagnostic and management conundrums. Am J Med Genet A. 2022;188:911\u201318.","journal-title":"Am J Med Genet A"},{"key":"1433_CR34","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1002\/mgg3.161","volume":"3","author":"D Bianchessi","year":"2015","unstructured":"Bianchessi D, Morosini S, Saletti V, Ibba MC, Natacci F, Esposito S, et al. 126 novel mutations in Italian patients with neurofibromatosis type 1. Mol Genet Genom Med. 2015;3:513\u201325.","journal-title":"Mol Genet Genom Med"},{"key":"1433_CR35","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s00439-021-02410-z","volume":"141","author":"H Kehrer-Sawatzki","year":"2022","unstructured":"Kehrer-Sawatzki H, Cooper DN. Challenges in the diagnosis of neurofibromatosis type 1 (NF1) in young children facilitated by means of revised diagnostic criteria including genetic testing for pathogenic NF1 gene variants. Hum Genet. 2022;141:177\u201391.","journal-title":"Hum Genet"},{"key":"1433_CR36","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1002\/humu.9446","volume":"27","author":"MJ Lee","year":"2006","unstructured":"Lee MJ, Su YN, You HL, Chiou SC, Lin LC, Yang CC, et al. Identification of forty-five novel and twenty-three known NF1 mutations in Chinese patients with neurofibromatosis type 1. Hum Mutat. 2006;27:832.","journal-title":"Hum Mutat"},{"key":"1433_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/GIM.0b013e3181bf15e3","volume":"12","author":"K Jett","year":"2010","unstructured":"Jett K, Friedman JM. Clinical and genetic aspects of neurofibromatosis 1. Genet Med. 2010;12:1\u201311.","journal-title":"Genet Med"},{"key":"1433_CR38","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1002\/humu.24222","volume":"42","author":"Y Zhai","year":"2021","unstructured":"Zhai Y, Zhang Z, Shi P, Martin DM, Kong X. Incorporation of exome-based CNV analysis makes trio-WES a more powerful tool for clinical diagnosis in neurodevelopmental disorders: a retrospective study. Hum Mutat. 2021;42:990\u20131004.","journal-title":"Hum Mutat"},{"key":"1433_CR39","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1038\/s41431-023-01312-0","volume":"31","author":"M Pennings","year":"2023","unstructured":"Pennings M, Meijer RPP, Gerrits M, Janssen J, Pfundt R, de Leeuw N, et al. Copy number variants from 4800 exomes contribute to ~7% of genetic diagnoses in movement disorders, muscle disorders and neuropathies. Eur J Hum Genet. 2023;31:654\u201362.","journal-title":"Eur J Hum Genet"},{"key":"1433_CR40","doi-asserted-by":"crossref","unstructured":"Royer-Bertrand B, Cisarova K, Niel-Butschi F, Mittaz-Crettol L, Fodstad H. Superti-Furga A CNV Detection from Exome Sequencing Data in Routine Diagnostics of Rare Genetic Disorders: Opportunities and Limitations. Genes. 2021;12:1427.","DOI":"10.3390\/genes12091427"},{"key":"1433_CR41","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1007\/s00439-023-02555-z","volume":"142","author":"M Koczkowska","year":"2023","unstructured":"Koczkowska M, Chen Y, Xie J, Callens T, Gomes A, Wimmer K, et al. Analysis of 200 unrelated individuals with a constitutional NF1 deep intronic pathogenic variant reveals that variants flanking the alternatively spliced NF1 exon 31 [23a] cause a classical neurofibromatosis type 1 phenotype while altering predominantly NF1 isoform type II. Hum Genet. 2023;142:849\u201361.","journal-title":"Hum Genet"},{"key":"1433_CR42","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.clindermatol.2020.03.010","volume":"38","author":"M Jafry","year":"2020","unstructured":"Jafry M, Sidbury R. RASopathies. Clin Dermatol. 2020;38:455\u201361.","journal-title":"Clin Dermatol"},{"key":"1433_CR43","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1055\/s-0040-1710524","volume":"51","author":"A Rademacher","year":"2020","unstructured":"Rademacher A, Schwarz N, Seiffert S, Pendziwiat M, Rohr A, van Baalen A, et al. Whole-exome sequencing in NF1-related West syndrome leads to the identification of KCNC2 as a novel candidate gene for epilepsy. Neuropediatrics. 2020;51:368\u201372.","journal-title":"Neuropediatrics"},{"key":"1433_CR44","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.1001\/jama.2009.1663","volume":"302","author":"L Messiaen","year":"2009","unstructured":"Messiaen L, Yao S, Brems H, Callens T, Sathienkijkanchai A, Denayer E, et al. Clinical and mutational spectrum of neurofibromatosis type 1-like syndrome. JAMA. 2009;302:2111\u20138.","journal-title":"JAMA"},{"key":"1433_CR45","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1038\/ejhg.2014.145","volume":"23","author":"E Pasmant","year":"2015","unstructured":"Pasmant E, Parfait B, Luscan A, Goussard P, Briand-Suleau A, Laurendeau I, et al. Neurofibromatosis type 1 molecular diagnosis: what can NGS do for you when you have a large gene with loss-of-function mutations? Eur J Hum Genet. 2015;23:596\u2013601.","journal-title":"Eur J Hum Genet"},{"key":"1433_CR46","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1056\/NEJMoa1800024","volume":"379","author":"A Weinberg-Shukron","year":"2018","unstructured":"Weinberg-Shukron A, Rachmiel M, Renbaum P, Gulsuner S, Walsh T, Lobel O, et al. Essential role of BRCA2 in ovarian development and function. N Engl J Med. 2018;379:1042\u201349.","journal-title":"N Engl J Med"},{"key":"1433_CR47","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1001\/archderm.144.3.418","volume":"144","author":"J Yoo","year":"2008","unstructured":"Yoo J, Wolgamot G, Torgerson TR, Sidbury R. Cutaneous noncaseating granulomas associated with Nijmegen breakage syndrome. Arch Dermatol. 2008;144:418\u20139.","journal-title":"Arch Dermatol"},{"key":"1433_CR48","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1002\/humu.23631","volume":"39","author":"EM Webber","year":"2018","unstructured":"Webber EM, Hunter JE, Biesecker LG, Buchanan AH, Clarke EV, Currey E, et al. Evidence-based assessments of clinical actionability in the context of secondary findings: updates from ClinGen\u2019s Actionability Working Group. Hum Mutat. 2018;39:1677\u201385.","journal-title":"Hum Mutat"},{"key":"1433_CR49","doi-asserted-by":"publisher","first-page":"S91","DOI":"10.1212\/WNL.0000000000012436","volume":"97","author":"C Bettegowda","year":"2021","unstructured":"Bettegowda C, Upadhayaya M, Evans DG, Kim A, Mathios D, Hanemann CO, et al. Genotype-phenotype correlations in neurofibromatosis and their potential clinical use. Neurology. 2021;97:S91\u201398.","journal-title":"Neurology"},{"key":"1433_CR50","doi-asserted-by":"publisher","first-page":"e616","DOI":"10.1002\/mgg3.616","volume":"7","author":"E Trevisson","year":"2019","unstructured":"Trevisson E, Morbidoni V, Forzan M, Daolio C, Fumini V, Parrozzani R, et al. The Arg1038Gly missense variant in the NF1 gene causes a mild phenotype without neurofibromas. Mol Genet Genom Med. 2019;7:e616.","journal-title":"Mol Genet Genom Med"},{"key":"1433_CR51","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-87686-x","volume":"11","author":"C Ejerskov","year":"2021","unstructured":"Ejerskov C, Gaustadnes M, Ostergaard JR, Krogh K, Thorsen K, Borglum AD, et al. Exploring associations between constipation, severity of neurofibromatosis type 1 and NF1 mutational spectrum. Sci Rep. 2021;11:9179.","journal-title":"Sci Rep"},{"key":"1433_CR52","doi-asserted-by":"crossref","unstructured":"Pacot L, Vidaud D, Sabbagh A, Laurendeau I, Briand-Suleau A, Coustier A, et al. Severe phenotype in patients with large deletions of NF1. Cancers. 2021;13:2963.","DOI":"10.3390\/cancers13122963"}],"container-title":["Journal of Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s10038-025-01433-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s10038-025-01433-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s10038-025-01433-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T22:01:56Z","timestamp":1777068116000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s10038-025-01433-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,10]]},"references-count":52,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["1433"],"URL":"https:\/\/doi.org\/10.1038\/s10038-025-01433-y","relation":{},"ISSN":["1434-5161","1435-232X"],"issn-type":[{"value":"1434-5161","type":"print"},{"value":"1435-232X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,10]]},"assertion":[{"value":"22 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 October 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}